← All decks

General Surgery

Perspective on Malignant Esophageal Disease (A)

Built from Maingot's Abdominal Operations

What’s inside

14 sections · 84 slides

  1. 01

    About this perspective

    A senior esophageal surgeon comments on three reviews, and says where he would do things differently

    • Purpose and scope of this perspective
    • Themes running through the commentary

    2 slides

  2. 02

    The rise of esophageal adenocarcinoma

    The largest epidemiologic change ever recorded for a solid cancer, and a hypothesis about what drives it

    • Scale and pattern of the rise
    • Reflux of stomach contents into the esophagus
    • The acid-suppression hypothesis
    • Symptom relief on medication and cancer odds
    • How a higher gastric pH lets bile acids act
    • From acid suppression to adenocarcinoma
    • Why severe persisting symptoms may carry less risk
    • Squamous, intestinalized and gastric linings meeting in one field
    • Goblet cells in intestinalized columnar lining

    9 slides

  3. 03

    Surveillance in Barrett's esophagus

    Taking issue with the dogma that watching a Barrett segment does not save lives

    • Surveillance and survival: the current dogma
    • Stage at detection in their own series
    • Surveillance biopsies in the lower esophagus

    3 slides

  4. 04

    Defining the gastroesophageal junction

    A boundary nobody can agree on, and the effect that has on counting cancers

    • Cardia cancers in the new staging system
    • Where the esophagus meets the stomach
    • The 2000 anatomic definition and its limits
    • A histologic definition of the junction
    • Types of metaplastic columnar lining
    • Consequences of counting the junction correctly

    6 slides

  5. 05

    High-grade dysplasia and endoscopic therapy

    How far endoscopy can go before the esophagus has to come out

    • High-grade dysplasia as the threshold for treatment
    • Endoscopic mucosal ablation versus esophagectomy
    • Visible lesions inside a flat Barrett segment
    • Depth of invasion decides the treatment
    • Depth of tumour invasion through the esophageal wall
    • The wall layers that matter for this decision
    • No safe level of submucosal invasion
    • Glandular cancer beneath the surface lining
    • Irregular malignant glands at high power
    • Training, workload and safety of endoscopic therapy
    • Patients unsuited to esophageal preservation
    • Normal hiatus compared with a hiatal hernia
    • Vagal sparing esophagectomy
    • Removing the diseased segment and rejoining the esophagus

    14 slides

  6. 06

    Choosing the operation

    Where the tumour sits decides what is done to it

    • When resection remains the mainstay
    • Treatment chosen by tumour site
    • Cervical cancer close to the cricopharyngeus
    • Lower cervical and upper thoracic tumours
    • Bowel used to replace the esophagus
    • Mid thoracic, lower thoracic, junction and cardia tumours
    • Stomach pulled up into the chest after total esophagectomy
    • Partial esophagectomy and rejoining

    8 slides

  7. 07

    Margins in an en bloc resection

    Clear edges in three directions, and what happens when they are not

    • The three margins that must be clear
    • Proximal margin length and specimen shrinkage
    • Radial margin and survival

    3 slides

  8. 08

    Lymphadenectomy

    How many nodes to remove, and the one prognostic factor the surgeon controls

    • Node count as a survival predictor
    • Ranking of the prognostic factors
    • Esophageal cancer spread to nearby lymph nodes
    • The third field: cervical node dissection
    • Nodes found during the initial neck dissection

    5 slides

  9. 09

    En bloc versus transhiatal resection

    Which patients actually gain from the bigger operation

    • Design of the comparison
    • What the comparison showed
    • Node count and the probability of systemic disease

    3 slides

  10. 10

    Ischemia of the reconstruction conduit

    The complication the author calls the Achilles heel of esophageal resection

    • Why the conduit is the weak point
    • Factors that contribute to conduit ischemia
    • Managing a worrisome conduit at operation
    • Delayed reconstruction after an ischemic conduit
    • Results of the delayed strategy

    5 slides

  11. 11

    Chemotherapy and chemoradiation

    Two decades of trials, and why the author thinks they answered the wrong question

    • Why the trials multiplied
    • Where the evidence stands
    • The staging flaw in the current trials
    • What neoadjuvant therapy actually achieves
    • Two trial designs worth running
    • Definitive chemoradiation and the case against surgery
    • < 2%
    • Centralization of esophageal surgery

    8 slides

  12. 12

    Technique of the tri-incision esophagogastrectomy

    Where this unit's version of the McKeown operation differs in detail

    • Starting in the right chest
    • Skeletonizing the aorta
    • Azygos vein and thoracic duct
    • Scar lines left by esophageal cancer surgery
    • Chest drainage after the resection
    • Effect of that drainage plan
    • Abdominal skeletonization
    • Exposing the inferior wall of the portal vein
    • Gastric conduit and pyloroplasty

    9 slides

  13. 13

    Minimally invasive esophagectomy

    What keyhole access has delivered, and where its limit lies

    • What the minimally invasive approach has delivered
    • Keeping the extent of the dissection
    • The limit of minimal access

    3 slides

  14. 14

    Key points

    What to carry away from this perspective

    • Key points: disease and diagnosis
    • Key points: treatment decisions
    • Key points: complications and the future
    • References
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    6 slides